• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eaton Vance Worldwide Health Sciences Fund

+ Add to Watchlist

ETHSX:US

12.81 USD 0.19 1.51%

As of 19:59:59 ET on 07/23/2014.

Snapshot for Eaton Vance Worldwide Health Sciences Fund (ETHSX)

Year To Date: +13.97% 3-Month: +9.21% 3-Year: +20.12% 52-Week Range: 9.64 - 12.92
1-Month: +2.07% 1-Year: +32.07% 5-Year: +18.88% Beta vs SPX: 0.92

Mutual Fund Chart for ETHSX

No chart data available.
  • ETHSX:US 12.81
  • 1M
  • 1Y
Interactive ETHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ETHSX

Eaton Vance Worldwide Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care.

Inception Date: 07-26-1985 Telephone: 1-617-482-8260
Managers: SAMUEL DAVID ISALY / SVEN H BORHO
Web Site: www.eatonvance.com

Fundamentals for ETHSX

NAV (on 2014-07-23) 12.81
Assets (M) (on 2014-06-30) 1,412.49
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 0.00

Dividends for ETHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-17) 0.20
Dividend Yield (ttm) 11.20

Fees & Expenses for ETHSX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.91
Redemption Fee 1.00
12b1 Fee 0.25
Expense Ratio 1.39

Top Fund Holdings for ETHSX

Filing Date: 05/31/2014
Name Position Value % of Total
Roche Holding AG 293,000 86,362,391 6.348%
Bristol-Myers Squibb Co 1,230,000 61,180,200 4.497%
HCA Holdings Inc 1,130,000 59,878,700 4.401%
AbbVie Inc 1,084,000 58,893,720 4.329%
Gilead Sciences Inc 675,000 54,816,750 4.029%
Merck & Co Inc 932,000 53,925,520 3.964%
Mylan Inc/PA 1,070,000 53,328,800 3.920%
Illumina Inc 326,400 51,652,800 3.797%
Allergan Inc/United States 289,200 48,429,432 3.560%
Biogen Idec Inc 149,600 47,777,752 3.512%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil